Restasis (ree-STAY-sis), a new cyclosporine emulsion for ophthalmic use

November 2010

Allergan is introducing Restasis (ree-STAY-sis), a new cyclosporine emulsion for ophthalmic use....

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get quote

Table of Contents

Gout Uloric, brings up questions about treating gout
Ophthalmology Restasis (ree-STAY-sis), a new cyclosporine emulsion for ophthalmic use
Ophthalmology Latisse (la-TEECE) will be the first drug on the market for increasing eyelash growth
Asthma Spiriva (TIOtropium) used in some patients with asthma
Gastroenterology whether sodium polystyrene sulfonate (Kayexalate, etc) is safe for hyperkalemia
Women's Health whether the new 10 mcg Vagifem (estradiol) vaginal tablet works as well as the 25 mcg strength
Pediatrics preventing iron deficiency in babies and toddlers
Pediatrics how well "no-touch" thermometers (Kidz-Med, Thermofocus, etc) work for checking fever
Substance Use Disorder People are abusing some unexpected OTC and Rx meds
Warts how to get rid of warts
OTC Products health hazards of misusing energy drinks
Obesity & Weight Loss what to do now that the weight loss drug sibutramine (Meridia, etc) is gone